Real-world everolimus experience in postmenopausal HR+ HER2- advanced breast cancer women: Treat ER+ight Canadian prospective observational study 2nd subgroup analysis
C. Doyle
◽
N. Califaretti
◽
S. Dent
◽
E. Chouinard
◽
S.R. Perri
◽
...
S Dent
◽
N Califaretti
◽
C Doyle
◽
C Ferrario
◽
E Chouinard
◽
...
LL McRoy
◽
D Mitra
◽
K Hollis
◽
JA Kaye
◽
A Zelnak
◽
...
2020 ◽
Vol 31
◽
pp. S1269
A.Y.P. Tai
◽
M. Singh
◽
J. Binko
◽
K. Lilly
◽
S. Chang
◽
...
2018 ◽
Vol 29
◽
pp. viii116-viii117
◽
D. Odom
◽
D. Mitra
◽
K. Hollis
◽
D. Richardson
◽
J.A. Kaye
◽
...
C Doyle
◽
N Califaretti
◽
S Dent
◽
N Iqbal
◽
M Mates
◽
...
A Fabi
◽
M De Laurentiis
◽
M Caruso
◽
E Valle
◽
L Moscetti
◽
...
Catherine Doyle
◽
Nadia Califaretti
◽
Cristiano Ferrario
◽
Nayyer Iqbal
◽
John Hilton
◽
...
A. Fabi
◽
D. Alesini
◽
M. De Laurentiis
◽
E. Valle
◽
D. Santini
◽
...
2020 ◽
Vol 31
◽
pp. S374-S375
C. Doyle
◽
T.A. Vandenberg
◽
C. Ferrario
◽
N. Califaretti
◽
N.N. Iqbal
◽
...
2019 ◽
Vol 30
◽
pp. iii51-iii52
A. Niyazov
◽
R.G.W. Quek
◽
K. Lewis
◽
J. Kemp
◽
A. Rider
Close
Export Citation Format
Close
Share Document
Close